MARTINI, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 5.888
NA - Nord America 5.338
AS - Asia 4.590
SA - Sud America 1.528
Continente sconosciuto - Info sul continente non disponibili 401
AF - Africa 146
OC - Oceania 3
Totale 17.894
Nazione #
US - Stati Uniti d'America 5.152
RU - Federazione Russa 3.447
SG - Singapore 2.242
BR - Brasile 1.312
CN - Cina 909
IT - Italia 730
IE - Irlanda 552
HK - Hong Kong 549
SE - Svezia 335
VN - Vietnam 237
FR - Francia 184
DE - Germania 169
BD - Bangladesh 156
IN - India 82
PL - Polonia 80
GB - Regno Unito 75
CA - Canada 74
ID - Indonesia 74
NL - Olanda 73
AT - Austria 69
AR - Argentina 66
FI - Finlandia 58
MX - Messico 54
TR - Turchia 43
ZA - Sudafrica 43
IQ - Iraq 38
CO - Colombia 35
EC - Ecuador 34
TH - Thailandia 33
VE - Venezuela 30
JP - Giappone 29
UZ - Uzbekistan 27
MA - Marocco 26
UA - Ucraina 25
TN - Tunisia 23
ES - Italia 19
PK - Pakistan 19
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
KE - Kenya 15
JM - Giamaica 14
PE - Perù 14
JO - Giordania 12
AZ - Azerbaigian 11
SA - Arabia Saudita 11
CI - Costa d'Avorio 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
EG - Egitto 9
KZ - Kazakistan 9
MY - Malesia 9
OM - Oman 9
PH - Filippine 9
UY - Uruguay 9
AL - Albania 8
KG - Kirghizistan 8
BG - Bulgaria 7
BH - Bahrain 7
CL - Cile 7
NP - Nepal 7
RO - Romania 6
RS - Serbia 6
GE - Georgia 5
IL - Israele 5
LB - Libano 5
LT - Lituania 5
NI - Nicaragua 5
NO - Norvegia 5
SN - Senegal 5
SV - El Salvador 5
TW - Taiwan 5
AO - Angola 4
BE - Belgio 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
PS - Palestinian Territory 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 17.476
Città #
Ashburn 1.179
Moscow 1.143
Singapore 769
Dublin 551
Hong Kong 542
San Jose 499
Dallas 394
Nyköping 296
Council Bluffs 275
Chandler 257
Princeton 240
Medford 204
Messina 201
Beijing 158
The Dalles 134
Lauterbourg 125
Los Angeles 121
Santa Clara 106
São Paulo 102
Columbus 95
Buffalo 77
Warsaw 71
Ho Chi Minh City 65
Guangzhou 61
Jakarta 58
Munich 57
Rome 54
Redondo Beach 53
Frankfurt am Main 50
New York 49
Hanoi 48
Milan 44
Belo Horizonte 42
Nuremberg 41
Rio de Janeiro 37
Vienna 35
Amsterdam 34
Orem 34
Bangkok 31
Catania 31
Montreal 30
Tianjin 28
Brooklyn 27
Shanghai 27
Atlanta 26
Brasília 26
Johannesburg 26
Porto Alegre 26
Stockholm 26
Tashkent 26
Des Moines 25
Turku 25
Chennai 23
Chicago 23
Tokyo 23
Lappeenranta 22
Denver 20
London 20
Mexico City 20
San Francisco 20
Phoenix 18
Curitiba 17
Xi'an 17
Salvador 15
Shenzhen 15
Campo Grande 14
Manchester 14
Quito 14
Seattle 14
Boston 13
São José dos Campos 13
Baghdad 12
Dong Ket 12
Florence 12
Nairobi 12
Paris 12
Santo André 12
Amman 11
Ankara 11
Baku 11
Campinas 11
Helsinki 11
Houston 11
Toronto 11
Abidjan 10
Fortaleza 10
Guarulhos 10
Lima 10
Miami 10
Mumbai 10
Naples 10
Pelotas 10
Sumaré 10
Turin 10
Xiamen 10
Casablanca 9
Caxias do Sul 9
Goiânia 9
Guayaquil 9
Istanbul 9
Totale 9.320
Nome #
Aggressive variants of follicular cell-derived thyroid carcinoma: an overview 203
Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia 194
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas 178
Short communication: proangiogenic hematopoietic cells in acute HIV infection 177
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 177
Mutations of the BIK gene in human peripheral B-cell lymphomas 176
PD-L1 expression in prostate cancer and Gleason Grade Group: Is there any relationship? Findings from a multi-institutional cohort 163
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 162
Histologic Evaluation of Thyroid Nodules Treated with Thermal Ablation: An Institutional Experience 162
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration 162
Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study 154
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 150
The Simultaneous Use of Bladder Epicheck® and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort 145
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism 144
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 142
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 140
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors 140
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 139
Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas 137
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples 136
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. 134
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features 132
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 130
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 129
The minefield of indeterminate thyroid nodules: could artificial intelligence be a suitable diagnostic tool? 121
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: new insights 119
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis 117
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology 115
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights 114
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 113
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 113
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ 112
Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology 110
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 109
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature 109
Rare histotypes of epithelial biliary tract tumors: A literature review 108
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy 107
First-line ICIs in renal cell carcinoma 107
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 107
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group 107
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review) 106
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study) 105
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 105
Immunoexpression of autophagy‑related proteins in a single‑center series of sporadic adult conventional clival chordomas 104
Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation 103
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation 103
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 102
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 102
Cuproptosis: A Review on Mechanisms, Role in Solid and Hematological Tumors, and Association with Viral Infections 102
DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis 101
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 101
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 101
Telomerase inhibition in malignant gliomas: a systematic review 101
null 100
A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants 100
The Role of Cytology in the Diagnosis of Subcentimeter Thyroid Lesions 99
Biomarkers of response to advanced prostate cancer therapy 99
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 99
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 99
Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection 99
Aseptic Loosening in Total Hip Arthroplasty: Pathophysiology, Biomarkers, and Preventive Treatment Strategies 98
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 97
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma 96
Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study 96
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 96
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker 96
The role of fine-needle aspiration in the thyroid nodules of elderly patients 96
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 95
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 95
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 94
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 93
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 92
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 92
Bleeding "sarcomatosis" as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature 92
Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker 90
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain Barrier 90
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillance 89
Morphology combined with ancillary techniques: an algorithm approach for thyroid nodules 89
Absence of structural mutations of the BAK gene in B cell lymphomas 89
Methylation study of the Paris system for reporting urinary (TPS) categories 89
Neuroimages and Neuropathology of a Stroke-Like Cerebral Lymphomatoid Granulomatosis 88
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 88
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 87
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 87
Targeting the tumor microenvironment in triple-negative breast cancer: Biological insights and therapeutic opportunities 87
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples 86
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 85
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores 85
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 85
Molecular testing in EBUS-TBNA specimens of lung adenocarcinoma: a study of concordance between cell block method and liquid-based cytology in appraising sample cellularity and EGFR mutations 85
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 84
The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques 84
To obtain more with less: cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 84
Understanding Neovascularization in Glioblastoma: Insights from the Current Literature 84
How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis 83
Is thyroid gland only a "land" for primary malignancies? Role of morphology and immunocytochemistry 83
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study 83
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells 82
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 82
The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology 82
Totale 11.083
Categoria #
all - tutte 66.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 3 0 1 10 3 12 6 2 1 11 484
2022/20231.561 248 111 78 63 50 133 46 66 643 19 26 78
2023/2024693 25 55 24 68 20 27 6 32 168 108 21 139
2024/20254.228 44 34 67 192 252 124 308 676 824 198 636 873
2025/202610.030 357 568 613 573 832 1.935 1.357 1.088 1.248 625 398 436
2026/2027729 305 424 0 0 0 0 0 0 0 0 0 0
Totale 17.894